Firm
King & Spalding has now hired 15 partners from Winston Taylor and legacy firm Winston & Strawn in offices spanning Texas, San Francisco, and Chicago
Firm says its work with a biotech client could signal a sea change in how - and when - law firms enter the drug development process
In an exclusive interview, Bernard Ledeboer reveals how a Consolid-backed group of firms wants to expand across Europe, invest in AI and centralise operations to compete at the top tier
Laura Achával, founder of Achával IP in Argentina, shares how an evolving vision led her to launch her own practice
Sponsored
Sponsored
-
Sponsored by Becerril, Coca & BecerrilSoledad Betanzos-Lara of Becerril, Coca & Becerril explains how Mexico’s pharmaceutical and biotech patentability criteria are being reshaped by evolving examination practice -
Sponsored by Tilleke & GibbinsChi Lan Dang of Tilleke & Gibbins explains how copyright arguments helped block a trademark application in Vietnam, highlighting a strategy for brand owners facing bad-faith filings without local rights
-
Sponsored by Tilleke & GibbinsWong Vorravitwattana and Nuttaphol Arammuang of Tilleke & Gibbins analyse a Thai court ruling that shows how trademark claims and interim relief can strengthen franchisor protection against post-termination operations
-
Sponsored by CASCAS provides practical pointers on how intellectual property and R&D teams can work in tandem to unlock tangible benefits and avoid wasted spend
-
Sponsored by CASCAS explores how AI is transforming intellectual property, from inventorship and copyright disputes to new demands on patent attorneys
-
Sponsored by That.LegalGillian Tan of That.Legal discusses a recent decision by the Intellectual Property Office of Singapore and what it reveals about the evidential burden in bad-faith trademark claims
